D. Hausenloy

Cardiology and Cardiovascular Medicine · 2002–2019

A researcher in the Science corpus: 11 papers; trusts 1 researcher and is trusted by 12 researchers here, as inferred from the citation graph.

Subfields

Whom D. Hausenloy trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. D. Yellon
  2. John A. Kellum
  3. A. Raffaello

Who trusts D. Hausenloy overall

  1. D. Yellon
  2. E. Murphy
  3. G. Heusch
  4. Theodore J Kalogeris
  5. A. Tsang
  6. S. Cadenas
  7. M. Mocanu
  8. C. Steenbergen
  9. Christopher P. Baines
  10. M. Krenz

Papers from D. Hausenloy's perspective

Ordered by how strongly the researchers D. Hausenloy trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. (American Journal of Physiology. Heart and Circulatory Physiology)
  2. Cyclosporine before PCI in Patients with Acute Myocardial Infarction. (New England Journal of Medicine)
  3. Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. (Cardiovascular Research)
  4. ERRATA (Nature Medicine)
  5. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. (Circulation)
  6. Preconditioning the myocardium: from cellular physiology to clinical cardiology. (Physiological Reviews)
  7. Interaction of Cardiovascular Risk Factors with Myocardial Ischemia/Reperfusion Injury, Preconditioning, and Postconditioning (Pharmacological Reviews)
  8. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1) (Critical Care)
  9. A 40 kDa protein of the inner membrane is the mitochondrial calcium uniporter (Nature)
  10. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. (The Lancet)

Their papers